Therapy News and Research

RSS

Combination drug therapy cures chronic hepatitis C in co-infected HIV patients

A multicenter team of researchers report that in a phase III clinical trial, a combination drug therapy cures chronic hepatitis C in the majority of patients co-infected with both HIV and hepatitis C.

21 Jul 2014

Discovery presents new challenges for HIV eradication efforts

The most critical barrier for curing HIV-1 infection is the presence of the viral reservoir, the cells in which the HIV virus can lie dormant for many years and avoid elimination by antiretroviral drugs. Very little has been known about when and where the viral reservoir is established during acute HIV-1 infection, or the extent to which it is susceptible to early antiretroviral therapy (ART).

21 Jul 2014

Researchers develop new single-cell technique to study environmental effects on DNA

Researchers at the BBSRC-funded Babraham Institute, in collaboration with the Wellcome Trust Sanger Institute Single Cell Genomics Centre, have developed a powerful new single-cell technique to help investigate how the environment affects our development and the traits we inherit from our parents.

21 Jul 2014

Scientists make seminal breakthrough in understanding molecular basis of fibroadenoma

A multi-disciplinary team of scientists from the National Cancer Centre Singapore, Duke-NUS Graduate Medical School Singapore, and Singapore General Hospital have made a seminal breakthrough in understanding the molecular basis of fibroadenoma, one of the most common breast tumours diagnosed in women.

21 Jul 2014

Brain network measures placebo effects in Parkinson's disease patients

Investigators at The Feinstein Institute for Medical Research have utilized a new image-based strategy to identify and measure placebo effects in randomized clinical trials for brain disorders. The findings are published in the August issue of The Journal of Clinical Investigation.

19 Jul 2014

Researchers receive nearly $3.6 million to create new National Clinical Trials Network

A team of physician-researchers from Huntsman Cancer Institute (HCI) at the University of Utah (U of U) has received nearly $3.6 million over the next five years in a cooperative agreement with the National Institutes of Health (NIH) to establish a Network Lead Academic Participating Site (NLAPS).

18 Jul 2014

13 researchers awarded National Psoriasis Foundation fellowship to study psoriasis

Twelve residents and medical students each received a one-year, $50,000 National Psoriasis Foundation fellowship to study psoriasis. The fellowships aim to increase the number of scientists studying and treating psoriatic disease by encouraging promising doctors to dedicate their careers to the study of psoriasis as physician researchers.

18 Jul 2014

Large proportion of PLHA in US are not sufficiently engaged in care and not taking ART

Regular attendance at HIV primary care visits and high adherence to antiretroviral therapy (ART) are vital for people living with HIV/AIDS (PLHA), as these health behaviors lead to lowered rates of morbidity and mortality, increased quality of life, and reducing the risk of HIV transmission to others.

18 Jul 2014

Phase II study reveals potential biomarker for HIV vaccine

Further analysis of a Phase II study of therapeutic HIV vaccine candidate Vacc-4x revealed a potential biomarker associated with participants who experienced a more profound viral load reduction after receiving the vaccine.

18 Jul 2014

Splice-switching oligonucleotide drugs alter editing of gene transcript

In splice-switching, an innovative therapeutic approach, targeted oligonucleotide drugs alter the editing of a gene transcript to produce the desired form of a protein.

18 Jul 2014

Salk scientists identify gene that fights metastasis of common lung cancer

Scientists at the Salk Institute have identified a gene responsible for stopping the movement of cancer from the lungs to other parts of the body, indicating a new way to fight one of the world's deadliest cancers.

18 Jul 2014

Study: Sleep problems after divorce may increase blood pressure

Those who experience persistent sleep problems after a divorce stand to suffer from more than just dark circles. They might also be at risk for potentially harmful increases in blood pressure, a new study finds.

18 Jul 2014

Difference between love and lust might be in eyes, say researchers

Soul singer Betty Everett once proclaimed, "If you want to know if he loves you so, it's in his kiss." But a new study by University of Chicago researchers suggests the difference between love and lust might be in the eyes after all.

18 Jul 2014

Researchers make significant breakthrough that may benefit patients with bowel cancer

Researchers at Queen's University have made a significant breakthrough that may benefit patients with bowel cancer.

18 Jul 2014

Gene therapy offers potential alternative to pacemakers

Researchers have developed a gene transplant procedure that can transform ordinary heart muscle cells into “biological pacemaker” cells that maintain heart rhythm.

17 Jul 2014

Ruthigen treats first human subjects with leading drug candidate RUT58-60

Ruthigen, Inc., today announced that it has treated the first human subjects with its leading drug candidate RUT58-60 in a 30 patient, 21-day skin irritation trial, which is expected to be completed in August 2014.

17 Jul 2014

MPP announces 7 new sub-licensing agreements for manufacture of generic HIV medicines

MPP forges first agreement with a Chinese manufacturer Desano; and with Cipla, Mylan and Micro Labs; Extends Collaborations with Aurobindo, Laurus Labs and Emcure

17 Jul 2014

FDA grants Breakthrough Therapy designation to Boehringer Ingelheim’s nintedanib

Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food & Drug Administration (FDA) has granted Breakthrough Therapy designation to nintedanib, an investigational therapy currently under FDA review for the treatment of people with idiopathic pulmonary fibrosis (IPF).

17 Jul 2014

Study examines mechanism of bone-protective properties of California dried plums

Fifty-seven million Americans suffer from low bone density or osteoporosis, a disease which causes bones to become so weak and brittle that even a minor fall or other stresses may cause fractures.

17 Jul 2014

Current recommendations advise prompt antiviral treatment for high-risk patients with influenza

Patients likely to benefit the most from antiviral therapy for influenza were prescribed these drugs infrequently during the 2012-2013 influenza season, while antibiotics may have been overprescribed.

17 Jul 2014

Therapy News and Research

Combination drug therapy cures chronic hepatitis C in co-infected HIV patients

Discovery presents new challenges for HIV eradication efforts

Researchers develop new single-cell technique to study environmental effects on DNA

Scientists make seminal breakthrough in understanding molecular basis of fibroadenoma

Brain network measures placebo effects in Parkinson's disease patients

Researchers receive nearly $3.6 million to create new National Clinical Trials Network

13 researchers awarded National Psoriasis Foundation fellowship to study psoriasis

Large proportion of PLHA in US are not sufficiently engaged in care and not taking ART

Phase II study reveals potential biomarker for HIV vaccine

Splice-switching oligonucleotide drugs alter editing of gene transcript

Salk scientists identify gene that fights metastasis of common lung cancer

Study: Sleep problems after divorce may increase blood pressure

Difference between love and lust might be in eyes, say researchers

Researchers make significant breakthrough that may benefit patients with bowel cancer

Gene therapy offers potential alternative to pacemakers

Ruthigen treats first human subjects with leading drug candidate RUT58-60

MPP announces 7 new sub-licensing agreements for manufacture of generic HIV medicines

FDA grants Breakthrough Therapy designation to Boehringer Ingelheim’s nintedanib

Study examines mechanism of bone-protective properties of California dried plums

Current recommendations advise prompt antiviral treatment for high-risk patients with influenza

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News